RDY Dr. Reddy's Laboratories Ltd Chart, History Price & Graph

Key Takeaways

• RDY exhibits a bearish trend, trading below all major moving averages from MA5 to MA200, signaling strong downward pressure.
• RSI(14) at 37.89 indicates sell territory nearing oversold, with STOCH(9,6) at 17.89 and Williams %R at -92.41 confirming oversold conditions.
• MACD(12,26) at -0.07 generates a sell signal, reinforced by ADX(14) at 48.01 showing strong trend strength in the bearish direction.
• Key support near 13.22-13.20, with immediate resistance at 13.29; pivot point at 13.27 defines the current trading range.
• Overall technical summary points to strong sell across indicators and moving averages.

Trend Analysis

The price chart of Dr. Reddy's Laboratories (RDY), a leading pharmaceutical company, reveals a clear downtrend over recent sessions. The stock has declined notably from its 52-week high near 16.17, now trading around 13.23. This bearish structure is evident as RDY remains firmly below its key moving averages, confirming sustained selling pressure. Price action shows consistent lower highs and lows, with recent sessions reflecting rejection at short-term resistance levels.

Support and Resistance Levels

Traders are eyeing critical support zones around 13.22 (S2) and 13.20 (S3), where accumulated volume may provide a floor. The classic pivot point stands at 13.27, acting as a neutral reference. Immediate overhead resistance emerges at 13.29 (R1), followed by 13.32 (R2) and 13.34 (R3). A sustained break below 13.20 could accelerate downside, while clearance above 13.29 might signal short-term relief. These levels, derived from recent price action, are pivotal in defining the stock's trading range amid reduced volatility.

Moving Averages

All moving averages flash sell signals, underscoring the bearish bias. The 5-day SMA sits at 13.28, with the 20-day SMA higher at 13.42 and 50-day SMA at 13.49. Longer-term averages, including the 100-day SMA at 13.50 and 200-day SMA at 13.38, further cap upside potential. RDY's position below these EMAs—from 5-day at 13.28 to 200-day at 13.54—highlights a lack of bullish momentum, with the price acting as dynamic resistance on pullbacks.

Momentum Indicators

Momentum indicators align with the downtrend. The RSI(14) reading of 37.89 resides in sell territory, approaching oversold levels without extreme divergence. MACD(12,26) at -0.07 confirms bearish crossover, while CCI(14) at -103.58 adds to the sell signals. Oversold readings in STOCHRSI(14) at 0 and Williams %R at -92.41 suggest potential exhaustion, though ADX(14) at 48.01 indicates robust directional strength favoring bears. These metrics point to continued weakness unless oversold conditions trigger a bounce.

Volume and Market Activity

Recent trading volume has accompanied price declines, reducing the risk of sharp reversals but affirming seller conviction. Average daily volume hovers around 2.5 million shares, with sessions showing alignment between volume spikes and downside moves. Less volatility per ATR(14) at 0.0729 implies consolidation potential within the defined range, where volume confirmation will be key for any directional shift.

AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast market data, technical indicators, and price patterns, generating actionable buy or sell signals for stocks like Dr. Reddy's Laboratories (RDY). These signals draw from trend recognition, historical pattern matching, and momentum analysis to pinpoint potential entry and exit opportunities. Traders rely on them to validate chart setups, time trades amid volatility, and bolster decision-making with data-driven insights. Explore the AI Daily Buy/Sell Signals to integrate advanced AI into your technical strategy.

Technical Outlook and Key Levels to Watch

Market participants will monitor whether RDY holds support at 13.22-13.20 amid oversold signals, potentially setting up a corrective bounce toward 13.29 resistance. A failure here could test deeper supports near the 52-week low of 12.77. Conversely, a decisive move above the pivot at 13.27 and short-term MAs might alleviate bearish pressure. Watch RSI for divergence, MACD for histogram shifts, and volume for breakout confirmation. The interplay of these elements will dictate near-term price behavior.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.